Musical chairs as AstraZeneca hires Roche Pharma COO Soriot as new CEO
This article was originally published in Scrip
Executive Summary
AstraZeneca has appointed Roche Pharma Chief Operating Office Pascal Soriot as the company's Chief Executive Officer. He will take on his new responsibilities and join the AstraZeneca PLC board as an Executive Director on 1 October 2012. Until then, Simon Lowth will remain as AstraZeneca's Interim Chief Executive Officer after which he will resume his responsibilities as Chief Financial Officer and AstraZeneca board member.